Boston University Libraries OpenBU
    JavaScript is disabled for your browser. Some features of this site may not work without it.
    View Item 
    •   OpenBU
    • Theses & Dissertations
    • Boston University Theses & Dissertations
    • View Item
    •   OpenBU
    • Theses & Dissertations
    • Boston University Theses & Dissertations
    • View Item

    The role of ATGL-1 in CeTOR regulated longevity in C. elegans

    Thumbnail
    Date Issued
    2020
    Author(s)
    Hechter, Drake
    Share to FacebookShare to TwitterShare by Email
    Export Citation
    Download to BibTex
    Download to EndNote/RefMan (RIS)
    Metadata
    Show full item record
    Permanent Link
    https://hdl.handle.net/2144/41700
    Abstract
    Aging is a major risk factor for many chronic diseases and a complex biological phenomenon. The most well studied and characterized pathways involved in metabolism and known to regulate longevity include sirtuins, AMP-activated protein kinase, insulin-like growth factor (IGF) and the mechanistic target of rapamycin (mTOR).1 These signaling pathways and related transcriptional factors are evolutionarily conserved from yeast to primates. Evidence suggests adipose tissue plays an important role in the regulation of lifespan particularly through energy homeostasis during times of scarcity and excess. Our laboratory has shown adipose triglyceride lipase (ATGL), the rate-limiting enzyme within the lipolytic pathway, is the target of dietary restriction and insulin/IGF-1 signaling pathways, both of which regulate lifespan.22 Given the convergence and necessity of ATGL-1 in the longevity response of dietary restriction and reduced insulin/IGF1 signaling pathways and the uncertainty of the downstream effects TOR has on longevity, we hypothesize that ATGL-1 plays an important role in CeTOR regulated longevity in C. elegans. This investigation was carried out by (a) determining whether levels of ATGL-1 are influenced by TOR inhibition via rapamycin and TOR specific RNA interference (RNAi) and (b) examining the role of ATGL-1 in CeTOR regulated longevity in C. elegans. We have found that rapamycin treatment does not increase expression of ATGL-1::GFP in C. elegans, however, continued research with CeTOR inhibition using rapamycin and RNAi treatment is necessary. The RNAi and longevity experiments need to be conducted. Tissue specific regulation of ATGL expression has been shown to be implicated in chronic disease and in longevity. However, there are still many insights to be discovered and understood about its role in longevity pathways, including feedback mechanisms and second messengers lipolytic products play. Elucidating the downstream effects of ATGL within model organisms will impact future chronic disease research and longevity studies. Given that these pathways are widely evolutionarily conserved, future findings will aid in understanding longevity regulatory mechanisms in humans.
    Collections
    • Boston University Theses & Dissertations [6915]


    Boston University
    Contact Us | Send Feedback | Help
     

     

    Browse

    All of OpenBUCommunities & CollectionsIssue DateAuthorsTitlesSubjectsThis CollectionIssue DateAuthorsTitlesSubjects

    Deposit Materials

    LoginNon-BU Registration

    Statistics

    Most Popular ItemsStatistics by CountryMost Popular Authors

    Boston University
    Contact Us | Send Feedback | Help